- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 88,320 | 21.06.24 15:05:18 | +1,130 | +1,30% | 88,280 | 88,390 | 87,640 | 88,320 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 987,600 | 21.06.24 15:58:34 | +19,200 | +1,98% | 981,200 | 987,200 | 968,800 | 987,600 |
